RenaissanceRe (NYSE:RNR) Given New $305.00 Price Target at Wells Fargo & Company

RenaissanceRe (NYSE:RNR) had its price objective lowered by Wells Fargo & Company from $306.00 to $305.00 in a report published on Thursday,Benzinga reports. The firm currently has an equal weight rating on the insurance provider’s stock.

A number of other research analysts have also commented on RNR. TD Cowen increased their price objective on RenaissanceRe from $280.00 to $290.00 and gave the company a “hold” rating in a research report on Thursday, February 26th. Evercore increased their price objective on RenaissanceRe from $283.00 to $291.00 and gave the company an “in-line” rating in a research report on Wednesday, February 4th. Citigroup increased their price objective on RenaissanceRe from $328.00 to $333.00 and gave the company a “neutral” rating in a research report on Wednesday, February 18th. Morgan Stanley lowered RenaissanceRe from an “overweight” rating to an “equal weight” rating and set a $310.00 price objective on the stock. in a research report on Thursday, February 26th. Finally, Wall Street Zen upgraded RenaissanceRe from a “hold” rating to a “buy” rating in a research report on Saturday, February 14th. Three research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $309.50.

RenaissanceRe Stock Up 0.9%

NYSE RNR opened at $309.87 on Thursday. The firm has a market cap of $13.37 billion, a PE ratio of 5.47, a price-to-earnings-growth ratio of 0.71 and a beta of 0.24. RenaissanceRe has a one year low of $222.75 and a one year high of $315.88. The stock’s 50 day simple moving average is $297.92 and its 200 day simple moving average is $276.20. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.43 and a quick ratio of 1.43.

RenaissanceRe (NYSE:RNR) last released its quarterly earnings results on Tuesday, February 3rd. The insurance provider reported $13.34 EPS for the quarter, topping analysts’ consensus estimates of $10.59 by $2.75. The business had revenue of $2.97 billion for the quarter, compared to analyst estimates of $1.73 billion. RenaissanceRe had a return on equity of 18.29% and a net margin of 20.88%.RenaissanceRe’s revenue for the quarter was up 29.6% on a year-over-year basis. During the same period in the prior year, the company earned $8.06 EPS. As a group, sell-side analysts forecast that RenaissanceRe will post 26.04 earnings per share for the current fiscal year.

RenaissanceRe Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 31st. Stockholders of record on Friday, March 13th were paid a $0.41 dividend. This is an increase from RenaissanceRe’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend was Friday, March 13th. This represents a $1.64 dividend on an annualized basis and a dividend yield of 0.5%. RenaissanceRe’s dividend payout ratio (DPR) is currently 2.89%.

Insider Buying and Selling at RenaissanceRe

In other news, EVP Robert Qutub sold 5,000 shares of the stock in a transaction on Friday, February 6th. The stock was sold at an average price of $305.75, for a total value of $1,528,750.00. Following the transaction, the executive vice president owned 73,023 shares of the company’s stock, valued at $22,326,782.25. This represents a 6.41% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 2.30% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in RNR. Lightrock Netherlands B.V. lifted its stake in shares of RenaissanceRe by 4,690.1% in the 4th quarter. Lightrock Netherlands B.V. now owns 1,017,508 shares of the insurance provider’s stock valued at $286,083,000 after purchasing an additional 996,266 shares during the period. Orbis Allan Gray Ltd acquired a new position in shares of RenaissanceRe in the 4th quarter valued at $178,519,000. Norges Bank acquired a new position in shares of RenaissanceRe in the 4th quarter valued at $168,582,000. Egerton Capital UK LLP acquired a new position in shares of RenaissanceRe in the 4th quarter valued at $137,944,000. Finally, GQG Partners LLC acquired a new position in shares of RenaissanceRe in the 4th quarter valued at $108,780,000. Institutional investors and hedge funds own 99.97% of the company’s stock.

Key RenaissanceRe News

Here are the key news stories impacting RenaissanceRe this week:

• Positive Sentiment: Cantor Fitzgerald upgraded RNR from Neutral to Overweight and raised its target to $340, signaling meaningful upside and helping support the rally. Cantor Fitzgerald Upgrade (Benzinga) Finviz
• Positive Sentiment: Barclays raised its price target sharply to $341 (from $310) while keeping an Equal Weight rating — a sizable lift to consensus targets that likely boosted investor optimism. Barclays PT Raise (Benzinga)
• Positive Sentiment: UBS bumped its target to $319 and reiterated a Neutral view, adding incremental upward pressure on the stock by increasing modeled value. UBS PT Raise (Benzinga)
• Positive Sentiment: Keefe, Bruyette & Woods published a note forecasting strong price appreciation for RNR, which reinforces buy-side thesis around underwriting leverage and capital return. Keefe, Bruyette & Woods Forecast
• Positive Sentiment: Zacks / industry commentary highlighted RNR among P&C insurers positioned to benefit from digitalization and pricing tailwinds after catastrophe activity — a sector-level bullish signal for premiums and renewals. Zacks Industry Outlook (Yahoo)
• Positive Sentiment: A Zacks piece listing “5 Stocks to Add From the Prospering P&C Insurance Industry” included RNR, reinforcing positive thematic interest from value and sector investors. Zacks: 5 P&C Stocks
• Neutral Sentiment: Zacks published an analysis asking whether value investors should buy RNR, providing balanced coverage that may attract research-driven flows but not an explicit buy signal. Zacks Stock Analysis
• Neutral Sentiment: AmericanBankingNews noted that brokerages’ consensus rating is roughly a “Hold,” which caps upside expectations until more positive revisions arrive. Brokerage Consensus (AmericanBankingNews)
• Neutral Sentiment: CNN Markets maintains a standard company profile page for RNR (useful for quote/activity context but not new directional news). CNN Markets: RNR
• Negative Sentiment: Wells Fargo trimmed its price target slightly from $306 to $305 and kept an Equal Weight rating — a modest negative signal that partially offsets the bullish broker activity. Wells Fargo PT Cut (Benzinga)

RenaissanceRe Company Profile

RenaissanceRe Holdings Ltd. is a global provider of reinsurance and insurance solutions, specializing in property catastrophe, casualty, and specialty lines. Established in 1993 and headquartered in Bermuda, the company trades on the New York Stock Exchange under the symbol RNR. With a focus on underwriting and risk assessment, RenaissanceRe offers tailored programs designed to help insurers and corporations manage exposure to natural disasters, liability claims, and other complex risks.

The company operates through two primary segments: Reinsurance and Insurance.